|Bid||159.06 x 800|
|Ask||159.08 x 1200|
|Day's range||158.60 - 160.78|
|52-week range||109.16 - 173.65|
|Beta (5Y monthly)||0.72|
|PE ratio (TTM)||28.91|
|Earnings date||20 Apr 2021|
|Forward dividend & yield||4.04 (2.55%)|
|Ex-dividend date||22 Feb 2021|
|1y target est||185.23|
Merck (MRK) is stepping up to help Johnson & Johnson (JNJ) produce its COVID-19 vaccine, which was authorized last weekend.
J&J CEO Alex Gorsky joins Yahoo Finance to discuss the company's successful journey to authorization of a COVID-19 vaccine.